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Abstract: Water damage in buildings is a universe problem. Long-lasting or cumulative stay in 
water damaged buildings is a serious health hazard. Exposure to fungal and bacterial toxins, 
nanoparticles from dampness microbiota as well as decay products from construction materials 
together with biocides used for cleaning will first cause irritation of the mucosa and later chronic 
inflammation with stimulation or inhibition of the compartments of the innate and/or adaptive 
immunity. Mold-related disease has been called Dampness and Mold Hypersensitive Syndrome 
(DMHS) because hypersensitivity is the cornerstone feature of the disease. The background of 
hypersensitivity is both immunologic processes and hyperactivation of sensory receptors, neurogenic 
inflammation and central sensitisation. Immunologic hypersensitivity can occur either through the 
production of mold specific IgE-class antibodies, which is rare, or through sensitisation and 
proliferation of T and B specific lymphocyte clones. Immunological switch to Th2/Th17 arm of 
adaptive immunity often occurs. DMHS is a systemic and multi-organ disease where involvement 
of mucosa of pulmonary or gastrointestinal tract is central to the pathology. Symptoms include 
recurrent infections, chronic rhinosinusitis, swelling of the sinuses, irritation of the eyes and skin, 
voice problems, chronic non-productive cough, neurological symptoms, joint and muscle 
symptoms, irritable bowel syndrome and cognitive problems. Underdiagnosed or neglected 
continuous insidious inflammation may lead to Myalgic Encephalitis/Chronic Fatigue Syndrome 
(ME/CFS) especially when trigged by new infections or even vaccination. Multiple Chemical 
Sensitivity (MCS) may also develop, however in the later stages of the disease. Chronic cough is 
sometimes diagnosed as asthma if the criteria for asthma are met. Non-productive cough may also 
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manifest allergic alveolitis, which is often overlooked. Avoidance of new exposure to dampness 
microbiota is crucial for recovery. We review the underlying toxicological and immunological 
mechanisms that are central in the pathology of DMHS. 
Keywords: dampness microbiota; asthma; allergic alveolitis; Dampness and Mold Hypersensitivy 
Syndrome; inflammation; mucosa 
 
1. Water damaged buildings: Why is the problem? 
Nearly 45 years ago, the energy crisis forced the Western world to think about energy-saving 
solutions. As a result, bottle-like buildings with linings made of plastic materials as vapour barriers 
were constructed. At the same time, natural air replacement has been changed for mechanical 
ventilation to recycle and filter indoor air and return warm air back. In the 1970s new and poorly 
studied building materials, adhesives, glues, etc. have been introduced by building industry. 
For example, in Finland, in the 70’s, building contractor training has been pushed down and 
buildings were designed to be poorly adapted to the harsh climate conditions. Buildings were built i.e. 
with flat roofs and cast plinths; the control of the constructions has been inadequate, and schedules 
were unrealistically tough to make the concrete dry completely. The use of air conditioning machines 
that may cause accumulation of water condensation along with the irregular filter replacement may 
cause over the years the growth of a moisture microbiota in homes and public buildings [1]. Already 
in the 1950s, moisture damage has been reported particularly in the base of the building that was 
caused by poor design and construction [2]. Climate change and abundant rainfalls may also 
contribute to increasing moisture damage problems [3]. 
In Norway, it has been found that up to 30% of residential buildings can be moisture 
damaged [3]. Similar estimates have also been published by the WHO highlighting that moisture 
damage is more common in poor residential areas [4]. In the United States it has been found that 
older homes without air conditioning are more likely to be moisture damaged [5]. Also, in public 
buildings and workplaces moisture damage is prevalent, but the extent of the damage is difficult to 
estimate [4]. In Finland, moisture damage occurs in at least 25% of school buildings [1] and even 
in 50–80% of small houses [2]. Dampness microbiota (DM) are not demanding for nutrients as 
virtually all organic matter is apt to be an energy source. Wood, plasterboard cardboard, wallpaper 
and other cellulose materials, and even ordinary room dust is apt nutrient for many microbes. For 
example, concrete, brick, lightweight barge and building boards may have microbial growth if there 
is dust or other dirt on the surface [6]. One should also consider the storage and preheating of home 
by mold-contaminated fire woods that is stored inside the building [7]. 
2. Clinical presentations of Dampness and Mold Hypersensitivity Syndrome 
Mold-related disease is multifaceted and has variable terminology. The term “Sick Building 
Syndrome” [8] is widely used in the context with DM. In a comprehensive review, the terms used for 
indoor air illness are summarized as follows: Mycotoxicosis, Mixed Mold Mycotoxicosis, Indoor 
Mold Sensitivity, Toxicity, Toxicity Induced Loss of Tolerance (TILT) [9], Chronic Inflammatory 
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Response Syndrome due to Water Damaged Buildings (CIRS WDB or CIRS) (Global Indoor Health 
Network (GIHN, [10]). In Finland it was called Dampness and Mold Hypersensitivity Syndrome 
(DMHS), and the clinical criteria have been laid [11]. In this review, we focus on the 
etiopathogenesis of DMHS trigged by biotoxins and structural components of DM. We will consider 
more deeply pulmonary manifestations of DMHS because immunological and toxicological effects 
of DM on mucosa of respiratory tract are studied the best. 
The susceptibility to disease may be genetic [12] or even epigenetic. In addition, cumulative 
exposure and the duration of the exposure is also relevant for morbidity [11]. Deficiency in some 
micronutrients such as vitamins and/or microelements as the factors predisposing to DMHS, have not 
yet been thoroughly studied. 
It is well known that stay in a water-damaged building can cause variable symptoms such e.g. as 
eye, ear and skin irritation, respiratory symptoms, increased infection sensitivity, pulmonary function 
changes, asthma, allergic alveolitis [3,4,8,10,13–18]. At the beginning exposure to DM typically 
leads to mild irritation symptoms that are reversible. At early stages persons can experience severe 
fatigue that does not improve with sleep. Avoiding exposure usually corrects the situation. If 
exposure occurs, for example, at work, the weekend relieves the symptoms, and the condition is called 
SBS. As exposure continues, the symptoms worsen and for example, the weekends become too short 
for recovery. Treatment of chronic disease is difficult because the person may experience the 
breakdown of the tolerance. Persons start to react towards many factors they could tolerate earlier. The 
symptoms of hypersensitivity may be symptom exacerbation during rainy and humid seasons [15,19]. 
Neurologic symptoms are common; joint and muscle pain and even overt rheumatoid arthritis is 
possible [10,20,21]. Development of autoimmune conditions and cancer has been reported [21]. 
Underdiagnosed or neglected continuous insidious inflammation may lead to ME/CFS especially 
when trigged by new infections or even vaccination [22]. MCS and Hypersensitivity to 
Electromagnetic field may also develop, however in the later stages of the disease [11]. Domestic 
animals and pets may also acquire disease in a mouldy environment [23]. 
3. Pulmonary manifestations are very common in Dampness and Mold Hypersensitivity 
Syndrome 
3.1. Upper respiratory system 
Chronic rhinitis is a symptom that lasts more than 12 weeks [12,24]. In vasomotor rhinitis, the 
mucosa reacts to various physical or chemical stimuli with sneezing, nasal discharge and 
congestion [24] and/or itching [12]. In DMHS allergic rhinitis may occur when an allergen, such 
substances from DM [15] reacts with specific IgE-class antibodies forming immunocomplexes on the 
surface of mast cells and basophils. When the person gets sensitized (s)he may react also to outdoor 
molds. Often, the symptoms present as rhinoconjuctivitis. The majority of asthmatics have also 
chronic rhinitis. Allergic rhinitis increases the risk for asthma [25]. 
Exposure to DM may associate with nasal polyposis [26]. Formation of biofilms on mucosa of 
sinus cavities has been considered as a major pathological hurdle [26]. Biofilm formation maintains 
chronic inflammation with an output of pro-inflammatory cytokines, the interleukin-17 in the first 
place [27]. Often, chronic rhinitis is unilateral, serous or purulent. Post nasal drip symptoms may last 
for years even after interruption of the exposure (T. Tuuminen, unpublished data). 
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3.2. Recurrent upper airway infections 
Rrecurrent or unusual infections and especially infections of respiratory tract are 
pathognomonic for DMHS [4,11,13,15–17,28]. Recurrent infections are considered those that occur 
more than 3/year and require medical treatment. In small children recurrent otitis media and sinusitis 
in adults are diagnosed in a great majority of exposed individuals. Bronchitis are also common [11,29]. 
When recurrent infections occur, health providers should get an alert of the possible infestation with 
DM at homes, nursing homes, schools or workplaces. 
3.3. Lower respiratory system 
Asthma is a chronic lung disease involving bronchial mucosal inflammation and smooth muscle 
hyperactivity which leads to bronchoconstriction sensitivity. Common symptoms include cough, 
mucous discharge, dyspnoea and wheezing [30]. Asthma is characterized by the accumulation of 
inflammatory cells such as mast cells, eosinophils, neutrophils, macrophages and T-helper cells on 
the mucous membrane and the underlying tissue. Pathophysiology of asthma is heterogeneous [30]. 
Cytokines and chemokines play an important role in pathogenesis. High serum IL-17A 
concentrations correlate with asthma severity and steroid resistance [31]. Asthma tends to be 
inherited by many factors. Diagnosis is based on auscultation, Peak Expiratory Flow (PEF), 
spirometry with bronchodilation and response to glucocorticoid therapy. Differential diagnosis 
requires X-ray imaging of the lungs and blood tests. 
Exposure to DM is known to cause elevated risk for asthma exacerbation and new  
asthma [4,13,15–17,28]. The newborn’s exposure to DM increases the risk of asthma in a child [32]. 
Increased admission of elderly people to hospital care due to asthma may associate with mouldy 
environment at homes [33]. With regard to asthma, a causal relationship between DM exposure and 
morbidity has been recently reviewed [34]. When asthma is caused by the exposure to DM, the 
symptoms may exacerbate at high outdoor mold content i.e. in late summer and autumn [15]. 
Symptoms are aggravated by rainy episodes and after the rainy days [15]. 
Poor indoor air may cause allergic alveolitis [4,12,17,35–38]. This condition is also called 
hypersensitivity pneumonitis. Similar condition caused by massive exposure to outdoor molds in  
so-called farmer’s disease was called Extrinsic Allergic Bronchiolo- Pneumonitis [39]. This 
condition has much in common with allergic alveolitis caused by indoor DM, although in the latter 
the person is exposed to biotoxins in addition to organic compounds. In our opinion hypersensitivity 
pneumonitis is better to call panbronchopneumonitis to highlight the involvement of all the 
pulmonary components such as bronchi and small bronchioli, parenchyma and interstitium. This 
condition refers predominantly to cell mediated lung disease that may be caused by inhalation of 
nanoparticles of organic content. As consequence of the exposure to DM the damage occurs to 
alveoli, terminal bronchi or interstitium. Inflammatory reaction will follow the exposure, but serum 
IgE levels are often normal [40]. Bronchoalveolar lavage (BAL) samples reveal elevated cytokine 
IL-8 production. CD4+ and CD8+ T lymphocyte counts are generally increased [40,41]. The cause 
of the disease is variable, often with fever, shortness of breath and cough [41]. 
Allergic Bronchopulmonary Aspergillosis (ABPA) is a given diagnosis often used instead of 
DMHS. ABPA is considered as an immunological pulmonary disorder caused by hypersensitivity to 
Aspergillus fumigatus which is a common species within DM, however not the only. The disease is 
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manifested as poorly controlled asthma, recurrent pulmonary infiltrates and bronchiectasis [42]. For 
ABPA, no agreement of the criteria nor treatment modalities are yet achieved within American 
Academy of Allergy, Asthma & Immunology [43]. It is however evident that the presence of IgE-
class antibodies should be detected to set the diagnosis of ABPA, but in our experience, this is a rare 
finding in DMHS. To emphasise that the etiology is broader this condition has been later called 
Allergic Bronchopulmonary Mucosis, ABPM [44]. By contrast, DMHS is a broader definition than 
ABPA/ABPM. DMHS may associate with other co-morbidities, such as e.g. neurologic, 
rheumatologic or g-i tract disorders, especially when DMHS goes chronic.  
ODTS (Organic Dust Toxic Syndrome) resembles allergic alveolitis and always manifests with 
fever. Common symptoms of over half of the patients are cough, laryngitis, tiredness, muscle and 
joint pain, headache, eye irritation, shortness of breath, nasal congestion, laryngeal irritation, itching 
and flushing, spasms and sometimes wheezing. Symptoms usually occur 4–8 hours after the 
exposure. Symptoms in ODTS are usually milder than those of allergic alveolitis. Symptoms may 
occur even from a single exposure. Unlike allergic alveolitis, the symptoms of ODTS disappear 
within 1 to 3 days and do not leave fibrosis or permanent changes in lung activity [45]. Diagnosis 
involves largely the same approaches as for allergic alveolitis. Radiological changes and lung function 
test abnormalities are not observed. In BAL, an increase in polymorphonuclear leucocyte and 
macrophage counts is observed, but there is no lymphocytosis indicative for immunoactivation [45]. 
ODTS occurs seldom in DMHS and is mentioned here for differential diagnosis. 
4. Dampness microbiota 
Dampness microbiota (DM) comprise molds, yeasts, Gram-positive and Gram-negative bacteria 
species. The following genera and species are often found: Aspergillus, Penicillium, Fusarium, 
Stachybotrys chartarum (“toxic black mold”), etc. Gram-positive bacteria may include 
Actinomycetes, Nocardia, Mycobacteria and Bacilli. DM is a so-called ecological community where 
species may vary over time depending on the microbial unrestricted competition for the availability 
of nutrition factors [4]. When humidity increases, microbial growth destroys building materials, 
resulting in volatile organic compounds (VOCs). DM itself emit into the air its own metabolism 
products (mVOC, microbial). Structural mold components, e.g. (1,3)-D-β-glucan [46] and 
galactomannans are modulators of the immunological system. Gram-negative bacteria produce 
lipopolysaccharide (LPS), a powerful activator of the immunological system. Molds secret exotoxins 
that split organic molecules, such as starch, cellulose and lignin. Exotoxins are strong allergens 
because they are proteins. They are active also when the soaked surface become dry [10]. DM may 
cause activation or deprivation of the immunological system, microbial colonization or sometimes 
even invasive infections [4,8,10,47–51]. There are thousands of studies on this topic; only GIHN [10] 
cites more than 400 peer-reviewed publications. 
The fragments of mold spores are small, about 2–10 μm. Aerodynamically, they can land on the 
small airway epithelium or penetrate even deeper into the lungs. On arrival at alveoli, the particles 
and toxins may reach the circulation system and thus be distributed to other organs [52,53]. 
In a moisture damaged building, a person is exposed to mycotoxins and other volatile 
components through the skin, mucosa or inhalation. Mycotoxins are in aerosol [54,55]. Air 
conditioning and heating enhance the aerosol particle movement [10]. Inhalation exposure, i.e. 
exposure through the respiratory tract is more dangerous than oral exposure because inhaled toxins 
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avoid the enterohepatic circulation where they may be detoxified by liver. Mycotoxins can alter the 
blood brain barrier (BBB) and enter the brain directly via Nervus olfactorius [56]. 
Many mycotoxins are lipophilic and are stored in adipocytes and in the brain, which is 
composed of various neurolipids. When the body’s capacity to acquire lipophilic toxins is saturated, 
it starts to react to hydrophilic substances [10]. Mycotoxins are small molecules, secondary 
metabolites of molds that can cause adverse effects on animal and human cells at very low 
concentrations [4,15,57]. Several mold genera such as Aspergillus, Penicillium, Fusarium, Alternaria 
and Stachybotrys produce mycotoxins [8,15]. Mycotoxins can up- or downregulate several genes, 
can inhibit DNA and RNA and protein synthesis, cause oxidative stress, some mycotoxins are 
vasoactive, some have cardiovascular effects, and many affect the immunological and 
(neuro)endocrine system [10]. Mycotoxins activate NLRP3 inflammasome [58]. Their effects on 
cellular levels are comparable to the effects of ricin, tobacco and asbestos [59] and can be used as 
biological weapon. 
Cytotoxic and immune-modifying effects are dependent on toxin concentrations [4,8,15,48,60] 
Toxins can potentiate the effects of each other [4,48]. Although respiratory effects of dampness 
microbiota were regarded as mycotoxicosis [8,48] a broader definition should be used. The term 
mycotoxicosis should be replaced by biotoxicosis [10] because bacterial toxins play also a big role. 
Trichothecenes and gliotoxin are probably the strongest known toxins [15]. Inhaled, toxic 
effects occur at a lower concentration than at oral administration [15]. T-2 and deoxynivalenol 
(vomitoxin) belonging to trichothecenes impair the immune response to respiratory infections [61]. 
T-2 toxin, patulin, penicillinic acid, aflatoxin, satratoxins have been shown to affect macrophage 
function and are cytotoxic [54]. Trichothecenes cause immunosuppression of lymphocytes and 
stimulate macrophages to produce IL-1β. These toxins inhibit protein synthesis in ribosomes, impair 
mitochondrial function, activate MAP kinase (MAPK) and induce apoptosis [59]. S. chartarum 
spores have been shown to affect apoptosis (programmed cell death) [56,62,63] while S. californicus 
spores cause cell cycle arrest [64]. 
The expression of genes was studied in the nasal mucosal epithelial cells and peripheral blood 
mononuclear cells from symptomatic and non-symptomatic individuals. It has been found that in 
symptomatic individuals there was increased expression of a few genes affecting calcium trafficking 
and MAPK signal transduction [65], neutrophil influx, production of TNFα cytokine, and 
immunosuppression [66]. 
Bleaching used for remediation, e.g. chlorine-containing biocides makes dampness microbiota 
more toxic and mutagenic because mycotoxins become better soluble in fat and therefore better 
penetrate the skin and stored in the adipose tissue and in the brain [10]. 
5. Immunologic responses to DM 
The immunological effects of the components of dampness microbiota are multilevel and partly 
even contradictory because they may inhibit and stimulate the innate and adaptive arms of immunity 
system [48,51,67,68]. The net effect depends on the composition of mycotoxins and on the growing 
species in the building. In different buildings, the ecological system is different. Therefore, the 
principles of serology applied from infectious diseases are generally not suitable for the diagnosis of 
a disease caused by dampness microbiota. Antibodies detected to mold species may only be 
indicative for the contact but do not have diagnostic value. In other words, increased antibody levels 
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poorly correlate with the occurrence and severity of the disease. Immunological response caused by 
dampness microbiota is very different from that of infections, since the presentation of antigens by 
dendritic cells to T lymphocytes is defective [10]. Generally, immunological responses to dampness 
microbiota is either of the type I (immediate reaction, e.g. IgE-mediated asthma, allergic rhinitis, 
Gell and Coombs classification) or the IV type, delayed, cell mediated response (allergic alveolitis). 
Importantly, the shift of Th1 immunological arm to Th17 immunity is associated with tissue 
damage [41]. Immunocomplexes are also found (Type III) with clinical signs of vasculitis  
(T. Tuuminen, unpublished data). 
Atopic individuals are more susceptible to develop asthma through IgE mediated response. 
However, only a small proportion of the patients develop allergy to the molds [4,11]. In one study, 
IgE class antibodies to different species were found in 30% of asthmatics [69]. In other studies, 
IgE antibody positivity was reported in only 10% [70]. The development of asthma has 
traditionally been studied on the basis of the mechanism mediated by allergens. However, there are 
strong indications that dampness microbiota can trigger pulmonary problems by allergen 
independent mechanisms [71,72]. 
Respiratory epithelial cells are an important protective barrier against stimuli. The epithelium 
acts as a mechanical protection and the cells secrete the mucus that removes foreign particles. These 
cells also secrete antimicrobial peptides and proteases that neutralize harmful agents [59]. The 
spermatotoxic effects of toxins have been described [73,74]. The tubular structure of the mammalian 
sperm tails and of the ciliated cells is identical [75], so the effects of myxotoxins on the spermatozoid 
cells can be extrapolated from the ciliated cells [76,77]. 
After the inhalation, the components of dampness microbiota (DM) activate several Pattern 
Recognition Receptors (PRR) on epithelial, macrophage and dendritic cells [78]. The most 
important of these are TLR2, TLR4 and TRL9 (Toll Like Receptors) [78,79]. As a result of this 
activation, an inflammatory process is initiated, whereby the cells produce immune mediators such 
as TNFα, interleukin-1β, chemokines and adhesion molecules [59]. Continuous overproduction of 
these pro-inflammatory molecules will damage the surrounding tissues and maintain chronic 
inflammation [80]. 
Many toxins are cytotoxic and may interfere with the opsonization of xenobiotics and inhibit 
phagocytosis by macrophages [81]. Because of this, macrophages may not be as efficient as in 
infections. For example, the Aspergillus fumigatus inhibits the action of dendritic cells [82]. 
Mannose binding lectin (MBL) is an important PRR structure. It is activated by the binding of 
β-glucans and galactomannans [46,83]. When this activation starts, its control is problematic. The 
maker of activation of innate immunity is the activation of the complement cascade with the elevated 
C4a concentrations as a fingerprint [84]. Macrophages produce transforming growth factor (TGF)-1β, 
matrix metalloproteinase-9 (MMP9). Neutrophils release proteolytic enzymes, such as serine 
proteases, and MMP9 that acts on the destruction of the alveoli, leading to chronic pulmonary 
fibrosis [46,59,79,82,83]. Pro-inflammatory cytokines also activate basophils and mast cells that 
release components of asurophilic granules such as histamine and bradykinin. The release of these 
bioactive amines can either be IgE mediated or without IgE. The most important feature of the 
pathogenesis is silent chronic inflammation, as well as oxidative and nitrosative stress reactions 
leading to cellular hypoxia and to the dysfunction of ion channels [47,51,67,79,85]. 
Interleukins and chemokines trigger adaptive immune response, e.g. proliferation of T- and B 
lymphocytes and memory cell formation. T lymphocytes differentiate into the Th17 subset. 
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Interleukin-17 produced by these cells together with TNFα attracts white blood cells to the 
inflammation site. The Th17 subset associates with autoimmunity and maintains inflammation [86]. 
Significant changes have also been observed in the impairment in B cell profiles [48]. Isolated 
mononuclear cells in upper respiratory tract of patients exposed to DM produce more IL-17, IL-10, 
TGF- β  and MIP-1β molecules [87]. A particularly interesting finding of epidemiological and 
experimental models is that β-glucans exacerbated allergic asthma and promoted the Th2/Th17 
immunological shift leading to steroid resistance [79]. 
6. Morphologic findings 
Studies of BAL fluid in rodents exposed to Stachybotrys spores demonstrated inflammatory 
changes in bronchioles and alveoli [88] and elevated counts of macrophages, neutrophils and 
lymphocytes, as well as increased levels of inflammatory cytokines [89]. Exposure of experimental 
animals to DM increased protein and lactate dehydrogenase levels in BAL and in the lung lesions [4]. 
In humans, histopathological changes resulting from DM exposure have been meticulously 
described [39] but these findings seem neglected by medical community. The pathology of 
hypersensitivity pneumonitis, or panbronchopneumonitis, or extrinsic allergic bronchilo-alveolitis (as 
has been named by the authors) was described. The authors performed electron microscopy in open 
lung biopsies of 13 patients with the so-called farmer’s lung and other mold exposure. “Eleven of the 
patients had farmer’s lung and two had been exposed to other mouldy dust. Numerous lymphocytes, 
macrophages and giant cells were present both in the alveolar and bronchiolar lumina. Bronchiolar 
changes included loss of microvilli on the ciliated cells, granulomas, detachment of basal cells from 
each other, as well as disintegration of the basement membrane. In the alveolus, hyperplasia and 
hypertrophy of type II (granular) pneumocytes often loosely connected with the basement membrane 
were frequently demonstrated. Disintegration of the basement membrane accompanied by 
detachment of the pneumocytes. In the interstitium lymphocytes, mast cells and plasma cells 
predominated. The size and shape of lymphocytes were variable. In addition, some lymphocytes with 
pseudopods were detected both in alveolar lumen and in the interstitium. Mast cells were found in 
close connection with plasma cells. In two patients there were granulomas consisting of mast, plasma 
and giant cells. Foreign material resembling hyphal fragments was found in the giant cells of two 
patients” (cited with minor abbreviations). The authors concluded that the presence of numerous 
plasma cells in the lung parenchyma suggested the possibility of local antibody response caused by 
exposure to inhaled antigens. 
Another study described a post-mortem examination of a bagpipe player who died from acute 
respiratory distress syndrome, hypersensitivity pneumonitis with diffuse alveolar injury and fibrosis 
of the interstitia. Paecilomyces variotti, Fusarium oxysporum, Penicillium species, Rhodotorula 
mucilaginosa and Trichosporon mucoides were isolated from the instrument. but microbial growth 
was not detected in the lung tissue [90]. 
In patients exposed to DM analysis of BAL revealed lymphocytosis and decreased CD19+ 
leukocyte counts in the peripheral blood sample [91]. In the BAL sample of patients with AA, a 
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7. Practical considerations 
Importantly, because mycotoxins are often cytotoxic, the lymphocyte count in BAL may be 
much lower than in other allergic alveolitis presentations, e.g. due to the exposure to other organic 
matter. In allergic alveolitis caused by DM imaging criteria may not be met either [18]. Changes in 
CD4+/CD8+ T lymphocytes, elevated IL-17 [87,91] and delayed cell-mediated hypersensitivity [92] are 
typical findings in the pulmonary pathology. The worst case scenario is that chronic inflammation 
turns to irreversible fibrosis [90]. 
Respiratory manifestations and rhinosinusitis may be long-lasting and difficult to treat [18]. The 
gold standard for treatment is avoidance of a new exposure [40]. It has been shown on a cellular 
level that the disease exacerbates with a continued exposure [40]. Remediation of a workplace 
prevents new workers from getting respiratory diseases, but the person once sensitized might not 
tolerate the air in the remediated building. Persons exposed to DM with chronic rhinosinusitis or 
respiratory problems are recommended to be placed in another workspace instead of just remediated 
building [18]. Noteworthy, movables contaminated with biotoxins can maintain symptoms [17]. 
Workplace PEF is still a diagnostic method for occupational asthma, at least in Finland. 
However, there are important ethical considerations to continue with this investigation. In the case of 
a workplace DM exposure the person will be deliberately exposed to biotoxins that will exacerbate 
the disease. Importantly, the safety of workplace PEF has been never demonstrated. Furthermore, 
workplace PEF is not suitable to diagnose allergic alveolitis. The authors of this article recommend 
workplace PEF should be abandoned in the context with DM [92]. Only safe methods should be used 
even at the expense of completeness of information. Work-related illness should be diagnosed from 
the patient’s medical history and documented SBS. In the future, new biomarkers will help diagnosis. 
Biopsy from a patient's bronchi, for example, is an invasive investigation that should be discouraged 
for routine use. Instead, analysis of tissue samples taken in any case for research purposes is ethically 
sustainable. 
Patients exposed to DM at homes or workplace often experience medical misconduct. The 
casualty between the exposure and the symptoms is often questioned, neglected and misinterpreted 
as a “nosebo effect” or purely as a “functional impairment”. Psychiatric and psychological factors as 
the background of the symptoms are apparently overestimated [10]. On the basis of presented 
immunological and toxicological evidence, it is high time to accept DMHS as a separate clinical 
entity and provide multidisciplinary care with appropriate social benefits. 
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